The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Annual Report and Notice of AGM

8 Apr 2022 14:19

RNS Number : 8429H
Arden Partners plc
08 April 2022
 

 

 

Arden Partners plc

("Arden" or the "Company" or the "Group")

Publication of Annual Report and Notice of Annual General Meeting

The Directors of Arden are pleased to advise that the Company's Annual Report for the financial year ended 31 October 2021 has today been published and is available for viewing on the Company's website,  www.arden-partners.com.

Also published today and available to view on the Company's website, is the Notice of Annual General Meeting, which will take place at the Company's office at 125 Old Broad Street, London EC2N 1AR on 28 April 2022 at 10.00 a.m.

The Annual Report and Notice of Annual General Meeting will be posted to all shareholders.

 

For further enquiries:

 

Arden Partners plc

Donald Brown - Chief Executive Officer

James Reed-Daunter - Executive Director

Steve Douglas - Group Finance Director

 

020 7614 5900

Houlihan Lokey UK Limited (NOMAD)

Tim Richardson

 

020 7484 4040

SEC Newgate Communications (Press enquiries)

Clotilde Gros/Richard Bicknell

 

020 7653 9850

 

Notes for editors

Arden is a dedicated corporate adviser and multi-service stockbroker to small and mid-cap companies in the UK and their investors.

 

The core purpose of our business is the effective management of the needs of our significant and growing base of corporate clients, and the effective support of their relationships with existing and potential shareholders.

 

These relationships are enhanced by the quality of our corporate finance advice and industry research, and the strong market presence of our sales and trading teams.

 

Our corporate finance capabilities encompass M&A, corporate finance advisory, broking and Sponsor and NOMAD services. We represent our clients in private transactions and Aquis, AIM and Main Market share issues.

 

Our research is designed to be sector focused, concentrating on top down thematic trends which highlight companies giving investors an exposure to the real growth areas of the small-cap and AIM markets.

 

The sales team's role is to keep institutions abreast of these themes and stock ideas. When there is a requirement for our corporate clients to raise money to fulfil their growth ambitions, the sales team is in a strong position to effect this, with its entrenched relationships with the UK institutional and non-institutional markets.

 

Our market making and trading teams provide liquidity in the shares of our corporate clients. We also trade the shares of non-client corporates on behalf of institutions.

 

The Arden Wealth Management team offers a bespoke service to our clients, with the ability to trade/invest in equities, bonds and a range of global investment funds, as well as allowing clients to participate in Primary and Secondary equity placings.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAFLFLVSDITIIF
Date   Source Headline
11th Mar 202112:30 pmRNSDirector/PDMR Shareholding
11th Mar 202110:55 amRNSHolding(s) in Company
3rd Mar 20218:53 amRNSShare Purchase By Employee Benefit Trust
2nd Mar 20214:11 pmRNSGrant of Options
2nd Mar 202110:21 amRNSShare Purchase by Employee Benefit Trust
18th Feb 20213:38 pmRNSPublication of Annual Report and Notice of AGM
17th Feb 202110:55 amRNSShare Purchase By Employee Benefit Trust
16th Feb 20217:00 amRNSAudited Results For The Year Ended 31 October 2020
11th Feb 20211:17 pmRNSDirector/PDMR Shareholding
12th Jan 20212:27 pmRNSDirector/PDMR Shareholding
11th Dec 202012:54 pmRNSDirector/PDMR Shareholding
11th Nov 20203:13 pmRNSTransaction in Own Shares
27th Oct 20209:43 amRNSShare Purchase by Employee Benefit Trust
13th Oct 202010:39 amRNSDirector/PDMR Shareholding
8th Oct 20209:43 amRNSShare Purchase by Employee Benefit Trust
17th Sep 202011:25 amRNSShare Purchase by Employee Benefit Trust
11th Sep 20208:43 amRNSDirector/PDMR Shareholding
7th Sep 202011:04 amRNSShare Purchase by Employee Benefit Trust
4th Sep 202011:57 amRNSShare Purchase by Employee Benefit Trust
11th Aug 20203:43 pmRNSDirector/PDMR Shareholding
11th Aug 20209:15 amRNSShare Purchase by Employee Benefit Trust
29th Jul 20209:05 amRNSShare Purchase by EBT and Holdings in Company
27th Jul 20207:00 amRNSInterim Results - Six Months Ended 30th April 2020
14th Jul 20209:56 amRNSDirector/PDMR Shareholding
9th Jul 20208:38 amRNSHolding(s) in Company
26th Jun 20209:08 amRNSShare Purchase By Employee Benefit Trust
11th Jun 20203:31 pmRNSDirector/PDMR Shareholding
11th Jun 20209:02 amRNSShare Purchase by Employee Benefit Trust
26th May 202011:00 amRNSHolding(s) in Company
26th May 202011:00 amRNSHolding(s) in Company
26th May 202010:58 amRNSDirector/PDMR Shareholding
26th May 20207:00 amRNSEmployee Incentivisation
21st May 20209:50 amRNSShare Purchase by Employee Benefit Trust
19th May 20207:00 amRNSHolding(s) in Company
12th May 20201:36 pmRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSTrading Update
24th Apr 202010:28 amRNSHolding(s) in Company
15th Apr 202012:24 pmRNSDirector/PDMR Shareholding
8th Apr 20208:43 amRNSHolding(s) in Company
30th Mar 202011:55 amRNSForm 8.5 (EPT/NON-RI)
25th Mar 20202:39 pmRNSResult of AGM
20th Mar 20207:00 amRNSStatement Re AGM and Change of Venue
19th Mar 20207:00 amRNSStatement Regarding Share Price Movement
11th Mar 20201:19 pmRNSDirector/PDMR Shareholding
18th Feb 20202:26 pmRNSPublication of Annual Report and Notice of AGM
11th Feb 20202:10 pmRNSDirector/PDMR Shareholding
3rd Feb 20207:00 amRNSPreliminary Results - Year Ended 31 October 2019
13th Jan 20201:51 pmRNSDirector/PDMR Shareholding
2nd Jan 202011:55 amRNSForm 8.5 (EPT/NON-RI)
31st Dec 201911:00 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.